Deepcell is a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research.
Location: United States, California, Menlo Park
Employees: 11-50
Total raised: $73M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Koch Disru... | kochdisrup... |
| 18.01.2022 | Fifty Year... | fiftyyears... |
| 17.06.2021 | a16z | a16z.com/ |
| - | Life Exten... | lifex.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2022 | Series B | $73M | - |
Mentions in press and media 11
| Date | Title | Description |
| 15.09.2025 | Deepcell and InGel Therapeutics Announce Strategic Partnership to Advance Next-Generation Ocular Cell Therapies | Integration of Deepcell's REM-I will enable high-dimensional, label-free single cell analysis and sorting to accelerate InGel’s therapeutic development pipeline Deepcell’s REM-I platform gives us the ability to interrogate single cells in n... |
| 24.04.2025 | Deepcell Appoints Janette Phi as Chief Business Officer, Raises Venture Round, and Expands to New Menlo Park HQ | Deepcell, Inc. As momentum builds, Deepcell advances commercial scale-up and market expansion for its AI-powered single cell analysis platform. Deepcell is at a pivotal inflection point, combining a world-class team, groundbreaking technolo... |
| 13.12.2024 | The Scientist Announces Its 2024 Top 10 Innovations Winners | The Scientist Announces Its 2024 Top 10 Innovations Winners The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom. WILMINGTON, Del., Dec. ... |
| 15.11.2023 | Deepcell Garners Industry Recognition for Disruptive AI-Driven Approach to Single Cell Morphology Analysis | Morpholomics builds momentum as Deepcell plans to share data generated by the REM-I platform at upcoming scientific meetings Deepcell, a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoverie... |
| 18.05.2023 | Deepcell Launches AI-Powered Single Cell Analysis Platform to Accelerate Cell Biology Discovery and Catalyze Field of Morpholomics | Benchtop REM-I Platform enables unprecedented insights into cell biology through scalable single cell imaging, high-dimensional analysis and cell sorting Company to present research at CYTO 2023 highlighting deep learning capabilities of it... |
| 06.02.2023 | Deepcell Releases First-of-Its-Kind Single Cell Morphology Data Sets | Generated by Deepcell’s Platform with an AI foundation model trained on millions of cell images, the data sets enable scientists for the first time to explore a novel multidimensional analyte Deepcell, a pioneer in AI-powered single cell an... |
| 02.11.2022 | Deepcell Expands Adoption of AI-Powered Morphology Characterization for Biological Researchers | Company initiates Scientific Summit and unveils library of new support resources for researchers to incorporate multidimensional morphology assessments into grant applications for increased funding Deepcell, a life science company pioneerin... |
| 19.03.2022 | Deepcell Scores $73M Series B | MENLO PARK, CA, Deepcell, a life science company, has closed its $73 million Series B round of financing led by Koch Disruptive Technologies. >> Click here for more funding data on Deepcell >> To export Deepcell funding data... |
| 18.03.2022 | Deepcell Raises $73 Million Series B Round to Advance Its AI-Powered Single Cell Analysis Platform | New funding to accelerate the scaling of operations and market introduction of its revolutionary “morpholomics” platform. Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translat... |
| 17.03.2022 | Deepcell Closes $73M Series B Financing | Deepcell, a Menlo Park, CA-based life science company pioneering AI-powered single cell classification and isolation for basic and translational research, closed its $73m Series B financing. This round, which brings Deepcell’s overall fundi... |
Show more